Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-03-02 @ 5:52 PM
Study NCT ID:
NCT00408967
Status:
WITHDRAWN
Last Update Posted:
2017-08-18
First Post:
2006-12-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.
Sponsor:
Organization: